Product Recalls in Delaware

Product recalls affecting Delaware — including food, drugs, consumer products, medical devices, and vehicles distributed to Delaware. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 1,099 recalls have been distributed to Delaware in the last 12 months.

48,330 total recalls
1,099 in last 12 months

Showing 641–660 of 13,379 recalls

DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Gabapentin Tablets 600mg Recalled by Glenmark Pharmaceuticals Inc., USA Due...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Pravastatin Sodium Tablets Recalled by Glenmark Pharmaceuticals Inc., USA...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Solifenacin Succinate Tablets 5mg Recalled by Glenmark Pharmaceuticals Inc.,...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Metformin Hydrochloride Extended-Release Tablets 1000mg Recalled by Glenmark...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Dr. Reddy's Laboratories, Inc.

Recalled Item: Levetiracetam 0.75% in Sodium Chloride Injection 1 Recalled by Dr. Reddy's...

The Issue: LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Nitroglycerin Sublingual Tablets 0.4MG 100-count carton Recalled by Glenmark...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Naproxen Sodium Tablets Recalled by Glenmark Pharmaceuticals Inc., USA Due...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Fenofibrate Capsules 67 mg Recalled by Glenmark Pharmaceuticals Inc., USA...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Frovatriptan Succinate Tablets 2.5mg Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Ranolazine Extended-Release Tablets 1000mg Recalled by Glenmark...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Pravastatin Sodium Tablets Recalled by Glenmark Pharmaceuticals Inc., USA...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Cetirizine Hydrochloride Tablets Recalled by Glenmark Pharmaceuticals Inc.,...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Fluphenazine Hydrochloride Tablets Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Lacosamide Tablets Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Propafenone Hydrochloride Extended-Release Capsules 225mg Recalled by...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Lacosamide Tablets 200mg Recalled by Glenmark Pharmaceuticals Inc., USA Due...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Propafenone Hydrochloride Extended-Release Capsules Recalled by Glenmark...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rosuvastatin Tablets 40mg Recalled by Glenmark Pharmaceuticals Inc., USA Due...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Indomethacin Extended-Release Capsules Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Clindamycin Hydrochloride Capsules Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund